{"id":"W34295218","doi":"10.1182/blood.v122.21.355.355","title":"Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Gemtuzumab ozogamicin; Induction chemotherapy; Internal medicine; Oncology; Chemotherapy regimen; Chemotherapy; Randomized controlled trial; Myeloid leukemia; Leukemia; Surgery; Stem cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007801853,0.0004396782,0.0007670654,0.000210574,0.0001744513,0.0003617143,0.0003680175,0.0003371766,0.001442537],"category_scores_gemma":[0.0005692947,0.000175427,0.0005132547,0.0002501038,0.0004811979,0.0002732518,0.0002281407,0.0009234524,0.0001836341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005246238,"about_ca_system_score_gemma":0.0005921922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009563896,"about_ca_topic_score_gemma":0.003770811,"domain_scores_codex":[0.9997839,0.0001238269,0.00001516758,0.00002475573,0.00002490513,0.00002745184],"domain_scores_gemma":[0.9997465,0.000053102,0.00007479938,0.00001421294,0.000009472591,0.0001019328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7778804,0.009015874,0.02564069,0.0009891676,0.001692876,0.0001561109,0.0001041874,0.002780975,0.01408794,0.0003701079,0.007443198,0.1598386],"study_design_scores_gemma":[0.5821326,0.2920814,0.1024278,0.0001947628,0.003209847,0.0004555441,0.00008713428,0.002294359,0.007259595,0.0003901464,0.009429058,0.00003771484],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938975,0.00325157,0.0001985611,0.0006152128,0.00009454728,0.0004016775,0.0008316215,0.00003350425,0.0006757895],"genre_scores_gemma":[0.9927965,0.003163991,0.0008179728,0.000501733,0.0001766699,0.0004185756,0.001349396,0.000007963732,0.0007672884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001442537,"threshold_uncertainty_score":0.00482583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009068426536026344,"score_gpt":0.2710262027850045,"score_spread":0.2619577762489781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}